Driven by expertise,
United by vision.

With decades of experience and a robust network within the biopharma and biotech industries, our team offers unparalleled insight into the scientific and financial landscapes. We are dedicated to identifying transformative therapies and supporting companies that are pioneering the future of healthcare.

RICARDO-BIOVANCE
Ricardo Perdigão Henriques, PhD

Managing Partner

João Incio, MD, PhD

General Partner

André Albergaria, PhD

Principal

Peter Villax

Non-Executive Partner

João Botelho

CFO

Yunyun Sun

Fellow

Ana Agostinho

Office Manager

Raquel Melo

Financial Manager

Ana Pinheiro

External Sustainability Consultant

Luis Alves da Costa 

Compliance Officer (Compass)

Supported by a multidisciplinary
advisory board.

Supported by a distinguished Scientific Advisory Board, Biovance Capital benefits from deep industry expertise and scientific insights to identify and advance breakthrough innovations in early-stage biotech.

Gonçalo Bernardes, PhD

Gonçalo Bernardes, PhD

Global Professor of Chemical Biology
at University of Cambridge

José Luís Cabero, Dr. Med Sc

José Luís Cabero, Dr. Med Sc

Consultant
at Symbiokraft, Spain

Kristina Beeler, PhD

Kristina Beeler, PhD

Chief Business Officer
at Biognosys, Switzerland

Mark Wilson, PhD

Mark Wilson, PhD

Consultant Strategic Technology
at Bioconsulting, UK

Riccardo Camisasca, MD

Riccardo Camisasca, MD

Global Head R&D
at Sumitomo Pharma, Switzerland

We help building leading companies with transformative treatments for patients in need

Visit our Portfolio